Nonthavej Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,325	2,372	2,484	2,472	2,255	1,786
Other Revenue	15.11	13.7	15.57	13.19	14.83	16.13
Revenue	2,341	2,386	2,500	2,485	2,270	1,802
Revenue Growth (YoY)	-5.51%	-4.56%	0.61%	9.45%	25.98%	-4.76%
Cost of Revenue	1,731	1,735	1,744	1,707	1,599	1,345
Gross Profit	609.89	651.06	755.76	777.82	671.24	457.29
Selling, General & Admin	328.28	329.43	328.42	311.51	290.96	262.07
Operating Expenses	325.58	327.5	325.21	306.18	300.65	266.56
Operating Income	284.31	323.56	430.55	471.64	370.59	190.73
Interest & Investment Income	19.87	21.72	19.02	11.69	4.54	3.56
EBT Excluding Unusual Items	304.17	345.29	449.57	483.33	375.13	194.3
Gain (Loss) on Sale of Investments	0.21	-0.03	-0.17	-0.08	-0.19	0.19
Pretax Income	304.38	345.25	449.4	483.25	374.94	194.49
Income Tax Expense	60.06	68.5	88.66	95.5	74.37	35.12
Net Income	244.32	276.76	360.74	387.75	300.56	159.37
Net Income to Common	244.32	276.76	360.74	387.75	300.56	159.37
Net Income Growth	-30.23%	-23.28%	-6.96%	29.01%	88.59%	-30.95%
Shares Outstanding (Basic)	160	160	160	160	160	160
Shares Outstanding (Diluted)	160	160	160	160	160	160
EPS (Basic)	1.53	1.73	2.25	2.42	1.88	1.00
EPS (Diluted)	1.53	1.73	2.25	2.42	1.88	1.00
EPS Growth	-30.23%	-23.28%	-6.96%	29.01%	88.59%	-30.95%
Free Cash Flow	209.7	202.49	356.72	408.45	379.07	111.13
Free Cash Flow Per Share	1.31	1.27	2.23	2.55	2.37	0.69
Dividend Per Share	1.040	1.040	1.370	1.460	1.130	0.600
Dividend Growth	-24.09%	-24.09%	-6.16%	29.20%	88.33%	-31.03%
Gross Margin	26.06%	27.29%	30.23%	31.30%	29.57%	25.38%
Operating Margin	12.15%	13.56%	17.22%	18.98%	16.32%	10.58%
Profit Margin	10.44%	11.60%	14.43%	15.60%	13.24%	8.84%
Free Cash Flow Margin	8.96%	8.49%	14.27%	16.44%	16.70%	6.17%
EBITDA	478.05	514.6	607.88	638.39	545.47	348.04
EBITDA Margin	20.42%	21.57%	24.32%	25.69%	24.03%	19.31%
D&A For EBITDA	193.74	191.04	177.33	166.75	174.88	157.3
EBIT	284.31	323.56	430.55	471.64	370.59	190.73
EBIT Margin	12.15%	13.56%	17.22%	18.98%	16.32%	10.58%
Effective Tax Rate	19.73%	19.84%	19.73%	19.76%	19.84%	18.06%
Revenue as Reported	2,341	2,386	2,500	2,485	2,270	1,802

Source: S&P Global Market Intelligence. Standard template. Financial Sources.